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ABSTRACT
Probiotics are live microbes that give many health benefits to human beings and animals, the most studied and commonly used probiotics 
are Gram-positive bacteria; lactobacilli and bifidobacteria. At nowadays, Lactobacillus spp. constitute more than two-thirds of the total 
numbers of probiotic species. The present study aimed to characterize Lactobacillus that locally isolated from human mouth and feces as 
probiotics. A total of three Lactobacillus isolates; Lactobacillus fermentum Lb2, Lactobacillus rhamnosus Lb9, and Lactobacillus paracasei 
Lb10 were investigated in respect to acid and bile salts tolerance, antibiotics susceptibility, and cell surface hydrophobicity in vitro using 
bacterial adhesion to hydrocarbons method. In comparison with the other two isolates, the isolate L. fermentum Lb2 was able to grow 
in all pH values and in the presence of different concentrations of bile salts. Antibiotics susceptibility profile showed that the tested 
Lactobacillus isolates were sensitive to ampicillin, amoxicillin, and erythromycin, while they were resistant to the other antibiotics that 
used in this study. L. fermentum Lb2 exhibited high surface hydrophobicity (77.26%), while the other tested isolates; L. rhamnosus Lb9 
and L. paracasei Lb10 revealed moderate adhesion abilities, 68.56% and 65%, respectively. L. fermentum Lb2 exhibited good probiotic 
behavior with respect to acid and bile salt tolerance as well as adhesion ability to hydrocarbons.
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INTRODUCTION
The attention of probiotic as an effective approach to prevent and treat a wide range of diseases is observed in recent years.[1] The term probiotic consists of two words 
which are pro, means for, and biotic, means life and totally 
means for life.[2] In 2001, the Food and Agriculture Organization 
of the United Nations and World Health Organization defined 
probiotics as “Live microorganisms which, when administered 
in adequate amounts, confer a health benefit on the host.”[3] 
The US Food and Drug Administration stated that the probiotic 
is considered as generally recognized as safe.[4] Many studies 
showed that probiotics are used effectively to do many 
beneficial functions to the host[5-9] when they are taken in 
adequate quantity, and the recommended dosage of them is 
ranged usually between 108 and 1010 CFU/day.[10]
Probiotics can be found in a wide assortment of 
commercial dairy products[11] as well as they can be prepared 
as capsules, powder, granules, and fermented or pelleted 
feed.[12] Microorganisms are considered as probiotic when 
they have several criteria such as the ability to adhesion to 
gastrointestinal tract, the ability to tolerance acidity and bile 
salts, and the resistance to antibiotics[13] have health benefits for 
the host[14] and safety.[15] The most commonly used probiotics 
are Lactobacillus and Bifidobacterium species.[16] Lactobacilli 
are the largest group included in lactic acid bacteria[15] 
and have many functions, such as improvement of growth 
performance and health of gastrointestinal tract, this answers 
why they are among the bacteria mostly used as probiotics 
in animal feeds and human foods.[17,18] The aim of this study 




A total of three locally Lactobacillus isolates were used in 
this study; Lactobacillus fermentum Lb2 that isolated from 
the mouth, Lactobacillus rhamnosus Lb9 and Lactobacillus 
paracasei Lb10 that isolated from feces.[19]
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Acid Tolerance Test
Fresh broth cultures of Lactobacillus isolates (Lb2, Lb9, 
and Lb10) were used at concentration of 1.5×108 CFU/ml 
according to McFarland tube No. 0.5 (Hardy Diagnostics, 
Santa Maria). Serial dilutions were made in tubes contain 
MRS broth (Oxoid, Germany), then bacteria were transferred 
individually to MRS broth at various pH values (2, 2.5, 3, 3.5, 
4, 4.5, 5, 5.5, and 6), and tubes were incubated at different 
times (1, 1.5, 2, 2.5, and 3 h) h; thereafter, 0.1 ml from 
each culture was taken and spread on MRS agar (Oxoid, 
Germany) with two replicates. Plates were incubated 
anaerobically for 24 h at 35°C. The pronounced colonies 
were counted, and results were recorded corresponding to 
control.[20]
Bile Salt Tolerance Test
Fresh broth cultures of Lactobacillus isolates (Lb2, Lb9, and 
Lb10) were used at the concentration of 1.5×108 CFU/ml 
according to McFarland tube No. 0.5. Serial dilutions were 
made in tubes contain MRS broth, then bacteria were 
transferred individually to MRS broth supplemented with 
various concentrations of bile salts (Difco, USA) (0.3%, 0.5%, 
and 0.7%), tubes were incubated at different times (1, 1.5, 
2, 2.5, and 3 h); thereafter, 0.1 ml from each culture was 
taken and spread on MRS agar with two replicates, and then 
plates were incubated anaerobically for 24 h at 35°C. The 
pronounced colonies were counted, and results were recorded 
corresponding to control.[21] The optical density of bacterial 
isolates growth in each bile salt concentration was measured 
at wavelength 660 nm after 3 h of incubation.
Antibiotics Susceptibility Test
Fresh broth cultures of Lactobacillus isolates (Lb2, Lb9, 
and Lb10) were used at concentration of 1.5×108 CFU/ml 
according to McFarland tube No 0.5; thereafter, 0.1 ml from 
each culture was taken and spread on MRS agar, and then 
antibiotics discs (25 µg ampicillin, 25 µg amoxicillin, 10 µg 
tetracycline, 1.25/23.75 µg trimethoprim-sulfamethoxazole, 
10 µg erythromycin, 10 µg gentamycin, 25 µg streptomycin, 
10 µg amikacin, 10 µg neomycin, and 10 µg chloramphenicol) 
(Bioanalyse, Turkey) were gently placed on MRS agar plates, 
plates were incubated anaerobically at 35°C for 24 h. The 
inhibition zones were measured and recorded; the work was 
done with two replicates.[22]
Cell Surface Hydrophobicity Test
It was determined in vitro using bacterial adhesion to 
hydrocarbons (BATH) method,[23] a fresh cultures of 
Lactobacillus isolates were subjected to centrifugation 
(6000 rpm, 10 min), cells were washed by phosphate buffer 
saline (Oxoid, Germany), resuspended in the same buffer 
and the optical densities of suspensions were adjusted to 
0.8–1 at (OD 560), and the data were recorded as A 0.6 ml 
of Lactobacillus suspensions were mixed with 1.2 ml of 
n-hexadecane (Sigma, USA), gently vortexed, and tubes were 
incubated anaerobically at 35°C for 30min. The mixtures were 
vortexed rigorously for 2 min and then allowed to stand for 
15 min at room temperature to ensure complete separation of 
the organic and the aqueous phase. The absorbance of aqueous 
phase was measured at 560 nm and recorded as A, the affinity 







A0, before adding n-hexadecane; A, after adding 
n-hexadecane.
Statistical Analysis
Statistical Analysis System[24] program was used to show the 
effect of different factors in study parameters. Furthermore, 
least significant difference (LSD) test was used to significant 
compare between means in this study.
RESULTS AND DISCUSSION
Probiotic strains must be able to survive and colonize in the 
presence of acidic conditions and bile salt so as to travel 
through the gastrointestinal tract and reach to digestive tract 
where they give their therapeutic effect to host.[25] In current 
study, three Lactobacillus isolates were subjected to different 
pH values with different incubation periods to examine their 
ability to tolerate acidic conditions. According to the results in 
Table 1, all three isolates were unable to grow at pH 2, while 
they were able to grow at all times of incubation at pH 4, 4.5, 
and 5 with a decline in their growth at pH 6 after its rise at 
pH 5.5. At pH 5, there was no significant difference in the 
growth of the three isolates except the 1st h of incubation with 
significant difference in time 3 h for Lb9.
The gradual decrease in the survival rate of bacterial 
growth, from pH 5 down to pH 2, as well as the decrease 
in bacterial growth at pH 6 after its increasing at pH 5.5 
can be observed, it seemed there is an affinity of the three 
isolates to pH 5.5 where their survival percentage reached the 
highest at this pH value, these results are similar to previous 
studies that used pH 5.5 in preparation of media as it allows 
optimum growth for Lactobacillus.[26,27] At pH 6, the reduction 
of the growth of the three isolates is noticeable at the 1st h of 
incubation while there was no significant difference in their 
growth in times 1.5 and 2 h for Lb2 and in times 2 and 2.5 h 
for Lb10. The significant decrease in the bacterial growth at 
the 1st h of incubation is due to the sudden change in pH as 
reported by Fernández-Calviño and Bååth.[28]
The ability of three Lactobacillus isolates to survive at three 
different concentrations of bile salts for different incubation 
periods was examined. The results in Table 2 show that all 
isolates were able to survive at all bile salts concentrations. 
The results of this study are agreed with previous studies 
used 0.3% and 0.5% of bile salts concentrations for 2.5 h of 
incubation.[29,30] The gradual decrease in the survival rate of 
bacterial growth as a result of the increase of concentration of 
bile salts can be observed. The significant decrease in bacterial 
growth at the 1st h of incubation is due to the sudden exposure 
to bile salts stress while there was no significant decrease in 
bacterial growth after the 1st h of incubation particularly at high 
concentration of bile salts. The resistance of Lactobacillus to 
bile salts may be due to different mechanisms such as changes 
in the composition of cell membrane and cell wall, active 
efflux of bile acids, and bile salt hydrolysis.[31] Figure 1 shows 
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the tolerance of Lactobacillus to three bile salts concentrations 
after 3 h of incubation.
For probiotic bacteria to be active for a long time in 
the gastrointestinal tract, they should be able to resist 
administrated antibiotics. In this study, ten antibiotics 
were used. The results in Figure 2 show that Lb2, Lb9, and 
Lb10 were highly sensitive to ampicillin, amoxicillin, and 
erythromycin; this was in accordance with reported by other 
authors.[32-35] For Lb2, the inhibition zone of ampicillin was 
higher than that of amoxicillin and erythromycin while the 
inhibition zones of these three antibiotics were the same for 
Lb9 while for Lb10, amoxicillin made a higher inhibition 
zone than other two antibiotics. Lb9 was resistant to 
trimethoprim-sulfamethoxazole, amikacin, and neomycin 
where there was no inhibition zone; these results are similar 
to those of Coppola et al.[36]
Table 1: Acid tolerance percentages of Lactobacillus isolates at different pH values
pH h Mean of viable count (log10 CFU/ml) Survival percentage
Lb2 Lb9 Lb10 Lb2 Lb9 Lb10
2.5 1 8.505B 8.612B - 2 3 0
3 1 8.748B 8.959B 8.643B
1.5 - 8.913a - 4 25 4
2 - 8.838a -
2.5 - 8.643b -
3.5 1 8.851B 9.017B 8.799B
1.5 8.740a 8.949a 8.505b
2 - 8.886b - 10 33 9
2.5 - 8.770b -
3 - 8.643b -
4 1 9.120B 9.086B 9.004B
1.5 9.110a 9.079a 8.959a
2 9.008b 9.004a 8.869a 46 45 39
2.5 8.954b 8.949b 8.819b
3 8.919b 8.892b 8.698b
4.5 1 9.178B 9.264B 9.093B
1.5 9.152a 9.136b 9.096a
2 9.123a 9.113b 9.079a 55 59 61
2.5 9.079b 9.071b 9.060a
3 8.963b 9.004b 9.045a
5 1 9.274B 9.204B 9.152B
1.5 9.276a 9.198a 9.130a
2 9.247a 9.146a 9.113a 77 64 66
2.5 9.235a 9.130a 9.086a
3 9.227a 9.123b 9.082a
5.5 1 9.298B 9.301A 9.250A
1.5 9.294a 9.278a 9.230a
2 9.271a 9.247a 9.204a 81 80 80
2.5 9.255a 9.230b 9.158b
3 9.247a 9.225b 9.130b
6 1 9.235B 9.206B 9.117B
1.5 9.220a 9.146a 9.082a
2 9.178a 9.127b 9.056a 65 59 58
2.5 9.143b 9.079b 9.045a
3 9.079b 9.075b 8.977b
Capital letters (A and B) indicate differences between the numbers of 1 h of incubation and control while the small letters indicate differences between 
the numbers of current hour and 1 h of incubation at P<0.05 based on the LSD test; A,aNo significant difference; B,bSignificant difference; -: No viable cells; 
Lb2: L. fermentum; Lb9: L. rhamnosus; Lb10: L. paracasei; missing pH (2) and hours, no viable cells
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Cell surface hydrophobicity of Lactobacillus isolates was 
determined to correlate the data with their ability to adhere 
to the intestinal epithelium. Cell surface hydrophobicity was 
determined using the method of BATH. The percent cell surface 
hydrophobicity was calculated, as shown in Table 3. According 
to three levels of hydrophobicity (low: 0–35%, medium: 
36–70%, and high: 71–100%) that determined by Ocana 
et al.[37] Lb2 showed a high hydrophobicity which was 77.26% 
while Lb9 and Lb10 showed medium hydrophobicity with 
percentage of 68.56% and 65%, respectively, the results of Lb2 
Table 2: Bile salt tolerance percentages of Lactobacillus isolates at different bile salts concentrations
Bile salt concentrations % h Mean of viable count (log10 CFU/ml) Survival percentage
Lb2 Lb9 Lb10 Lb2 Lb9 Lb10
0.3 1 9.385A 9.372B 9.245B 70 68 58
1.5 9.369a 9.332a 9.212a
2 9.235b 9.278b 9.133b
2.5 9.193b 9.262b 9.130b
3 9.146b 9.260b 9.079b
0.5 1 9.305B 9.324B 9.103B 52 49 43
1.5 9.176b 9.206b 9.089a
2 9.133b 9.146b 9.021a
2.5 9.082b 9.082b 8.924b
3 8.991b 8.968b 9.004a
0.7 1 9.170B 9.060B 9.068B 42 30 44
1.5 9.117a 9.029a 9.060a
2 9.045b 8.954a 9.056a
2.5 9.029b 8.857b 9.037a
3 8.908b 8.851b 9.017a
Capital letters (A and B) indicate differences between the numbers of 1 h of incubation and control while the small letters indicate differences between the 
numbers of current hour and 1 h of incubation at P<0.05 based on the LSD test; A,aNo significant difference; B,bSignificant difference (P<0.05); Lb2: L. fermentum; 
Lb9: L. rhamnosus; Lb10: L. paracasei
Table 3: Cell surface hydrophobicity of Lactobacillus isolates
Lactobacillus isolates Absorbance Hydrophobicity percentage
A0 A
Lactobacillus fermentum Lb2 0.8273 0.1881 77.26 (high)
Lactobacillus rhamnosus Lb9 0.9965 0.3132 68.56 (medium)
Lactobacillus paracasei Lb10 0.8206 0.2872 65.00 (medium)
A0: Before adding n-hexadecane; A: After adding n-hexadecane; low: 0–35%; medium: 36–70%; high: 71–100%
Figure 1: Tolerance of Lactobacillus isolates; Lb2, Lactobacillus 
fermentum; Lb9, Lactobacillus rhamnosus; and Lb10, Lactobacillus 
paracasei to bile salts concentrations (0.3%, 0.5%, and 0.7%)
Figure 2: Antibiotics susceptibility test of Lactobacillus 
isolates; AM: Ampicillin; AX: Amoxicillin; TE: Tetracycline; 
SXT: Trimethoprim-sulfamethoxazole; E: Erythromycin; CN: Gentamycin; 
S: Streptomycin; AK: Amikacin; N: Neomycin; C: Chloramphenicol
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and Lb9 are similar to previous study of García et al.[35] The 
BATH test quantifies the surface hydrophobicity of bacteria, 
and it has widely been used to estimate the physicochemical 
component in adhesion ability of bacterial strains.[38] Hence, 
based on the hydrophobicity or the charge of the bacterial 
outer layer, the adhesion ability to hydrophobic surfaces such 
as mucus can be characterized indirectly.[39]
However, consumption products that contain probiotic 
bacteria such as dairy products and fermented vegetables as 
well as eat healthy foods rich in fibers and prebiotics will 
contribute to increase the numbers of these useful bacteria 
in our gastrointestinal tract, and this lead to reestablishment 
of normal microbiota balance and enhancement their 
activities.
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CONCLUSION
Depending on the results of this study, the bacterial isolate 
L. fermentum Lb2 showed up good probiotic behavior in 
respect of acid and bile salt tolerance and adhesion ability to 
hydrocarbons. However, more studies are required about this 
isolate and thus could be good candidate to use as probiotic.
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